Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT02201108 · COMPLETED
Trial details
- NCT number
- NCT02201108
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-16
- Primary completion
- 2019-10-25
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.